Man Group
COLL icon

Man Group’s Collegium Pharmaceutical COLL Stock Holding History

Man Group’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-72,182
Closed -$2.39M – 2380
2026
Q1 		$2.39M Buy
72,182
+23,725
+49% +$1M ﹤0.01% 1500
2025
Q4 		$2.24M Sell
48,457
-45,455
-48% -$1.9M ﹤0.01% 1410
2025
Q3 		$3.29M Buy
93,912
+15,661
+20% +$544K 0.01% 1235
2025
Q2 		$2.31M Sell
78,251
-26,636
-25% -$760K ﹤0.01% 1352
2025
Q1 		$3.13M Sell
104,887
-113,545
-52% -$3.47M 0.01% 1194
2024
Q4 		$6.26M Sell
218,432
-122,142
-36% -$4.04M 0.02% 933
2024
Q3 		$13.2M Sell
340,574
-36,851
-10% -$1.31M 0.03% 611
2024
Q2 		$12.2M Buy
377,425
+116,489
+45% +$4.04M 0.03% 623
2024
Q1 		$10.1M Buy
260,936
+204,957
+366% +$7.17M 0.03% 692
2023
Q4 		$1.72M Buy
+55,979
New +$1.4M ﹤0.01% 1320
2023
Q3 		– Sell
-43,100
Closed -$983K – 1255
2023
Q2 		$926K Buy
+43,100
New +$979K ﹤0.01% 1408
2021
Q1 		– Sell
-20,470
Closed -$410K – 1867
2020
Q4 		$410K Sell
20,470
-1,500
-7% -$29.3K ﹤0.01% 1591
2020
Q3 		$457K Sell
21,970
-1,953
-8% -$35.3K ﹤0.01% 1562
2020
Q2 		$419K Sell
23,923
-8,508
-26% -$167K ﹤0.01% 1492
2020
Q1 		$530K Buy
+32,431
New +$669K ﹤0.01% 1270
2018
Q4 		– Sell
-19,445
Closed -$287K – 1948
2018
Q3 		$287K Buy
+19,445
New +$345K ﹤0.01% 1966

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Man Group's COLL Position: Q2 2026 in Review

Man Group sold out of Collegium Pharmaceutical (COLL) in Q2 2026, closing a stake of 72,182 shares — an estimated $2.39M sold.

Man Group first reported a position in COLL in Q3 2018 and held it in 16 quarters. The position peaked at $13.2M in Q3 2024. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Man Group reported no remaining Collegium Pharmaceutical position as of Q2 2026 after selling out during the quarter.
  • Man Group sold 72,182 Collegium Pharmaceutical shares in Q2 2026, an estimated $2.39M.
  • Man Group first reported a position in Collegium Pharmaceutical in Q3 2018 and held it in 16 quarters.
  • Man Group's Collegium Pharmaceutical position peaked at $13.2M in Q3 2024.
  • 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.